In line with this, lupeol, a precursor of lupenyl acetate, has been demonstrated to inhibit melanoma cell metabolism in vitro through various mechanisms including induction of differentiation [41], and the inhibition of mitogen-activated protein kinase p38 (MAPK) [42]. This evidence concerns the gene MAPK14 and melanoma.